Surfside, Florida · Physician-Ordered

Horizon Screening.

Carrier Screening · 200+ Conditions · Preconception & Pregnancy

A preconception and prenatal carrier screening panel covering 200+ recessive genetic conditions including Cystic Fibrosis, Spinal Muscular Atrophy, Fragile X, and Tay-Sachs. Single blood draw, results in 2 to 3 weeks, reviewed with our board-certified physician team for family planning decisions.

200+
Conditions Screened
Preconception / Pregnancy
Both Phases Served
2-3 wk
Results Turnaround
JC
Joint Commission Accredited
Quick Answer

What is Horizon carrier screening?

In one paragraph
Horizon is a physician-ordered carrier screening panel from Natera that analyzes 200+ recessive genetic conditions. It identifies whether you (and ideally your reproductive partner) carry a single copy of a mutation that, if both partners carry it for the same condition, would create a 25% risk in each pregnancy. It is the standard of care for preconception and early-pregnancy planning under ACOG and ACMG guidance.
Conditions Screened

What This Screening Detects.

Horizon screens for over 200 inherited recessive and X-linked conditions. The panel covers conditions universally recommended by ACOG and ACMG plus expanded categories that historically were limited to specific ancestries.

Cystic Fibrosis
CFTR — one of the most common autosomal recessive disorders; carrier rate ~1 in 25 in non-Hispanic white populations.
Spinal Muscular Atrophy
SMN1 — carrier screening recommended for all patients planning pregnancy, regardless of ancestry.
Fragile X Syndrome
FMR1 — the most common inherited cause of intellectual disability, X-linked.
Tay-Sachs & Canavan Disease
HEXA, ASPA — elevated carrier frequency in Ashkenazi Jewish, French Canadian, and Cajun populations.
Sickle Cell & Thalassemias
HBB, HBA1, HBA2 — elevated frequency in African, Mediterranean, and Southeast Asian ancestries.
Gaucher, Niemann-Pick, Bloom, Mucolipidosis IV
Lysosomal storage and other conditions with elevated Ashkenazi Jewish carrier frequency.
Familial Dysautonomia, Phenylketonuria
IKBKAP, PAH — metabolic and neurological recessive disorders included in the expanded panel.
Duchenne Muscular Dystrophy
DMD — X-linked, severe; carrier identification informs reproductive planning.
Clinical Performance

Natera Horizon · by the numbers.

Horizon is the carrier screening panel from Natera, a genetics laboratory that processes more than two million reproductive-health tests annually. Performance and panel data come from Natera’s published technical documentation.

274
Conditions Screened
The full Horizon pan-ethnic panel covers up to 274 autosomal-recessive and X-linked genetic conditions — from common (cystic fibrosis, SMA) to ultra-rare lysosomal storage disorders.
Source: Natera Horizon clinician page
5
Panel Sizes Available
From a 4-condition core panel (ACOG minimum) to the full 274-condition expanded panel — your physician selects the panel that matches your ancestry, family history, and reproductive plans.
Source: Natera Horizon panel options
2–3 wk
Lab Turnaround
Typical time from sample arrival at the Natera lab to a finalized report. Time-sensitive prenatal cases can be flagged for priority handling.
Source: Natera provider workflow documentation
Blood or saliva
Sample Type
A standard venous blood draw at our Surfside clinic, or a needle-free saliva kit for at-home collection — equally accurate.
Source: Natera collection protocols
~80%
Carry ≥1 Recessive Variant
Roughly 4 in 5 healthy adults are silent carriers of at least one recessive condition. Carrier status only matters reproductively when both partners carry a variant in the same gene.
Source: Published carrier-frequency literature
Genetic Counselor
Included with Result
Every Horizon order includes complimentary access to Natera board-certified genetic counselors for pre-test and post-test consultation — in addition to your TrufaMED physician review.
Source: Natera Horizon clinical support
Why Screening Matters

Carrier rates are higher than most expect.

Most carriers are entirely healthy and have no family history. Routine screening is the only way to know your status before a child is conceived. Approximate population carrier frequencies for the most clinically common conditions on the Horizon panel:

Cystic Fibrosis (CFTR)

~1 in 25 (Northern European) · ~1 in 24 (Ashkenazi Jewish) · ~1 in 65 (African American)

The most common life-shortening recessive condition in people of European descent.

Spinal Muscular Atrophy (SMN1)

~1 in 50 (general U.S. population)

SMA is the leading genetic cause of infant mortality — now treatable when identified at birth, but prevention via carrier screening remains the gold standard.

Fragile X (FMR1)

~1 in 150 women carry a premutation

Leading inherited cause of intellectual disability and autism — only the maternal partner is screened.

Tay-Sachs (HEXA)

~1 in 27 (Ashkenazi Jewish, French Canadian, Cajun) · ~1 in 250 (general)

Severe neurodegenerative disorder of infancy — carrier screening reduced incidence by >90% in target populations.

Sickle Cell Disease (HBB)

~1 in 13 (African American)

The most common single-gene disorder in the United States.

Beta Thalassemia (HBB)

Elevated in Mediterranean, Middle Eastern, South Asian ancestry

A spectrum of severity — combined with sickle-cell variants, can produce severe disease.

If Both Partners Are Carriers

A 25% chance — and a real plan.

When both reproductive partners carry a pathogenic variant in the same recessive gene, each pregnancy has a 25% chance of being affected. That number is real — and so are the options. Our physicians refer to maternal-fetal medicine and reproductive endocrinology specialists when warranted.

Preconception Path

If you screen before pregnancy, options include in-vitro fertilization with preimplantation genetic testing for monogenic disorders (IVF with PGT-M), donor gametes, adoption, or proceeding naturally with prenatal diagnosis.

Prenatal Path

If you screen during pregnancy, diagnostic options include chorionic villus sampling (CVS) at 10–13 weeks or amniocentesis at 15–20 weeks to test the fetus directly.

Informed Preparation

Many couples choose to continue the pregnancy with full knowledge — arranging delivery at a tertiary center, lining up specialists, and preparing the home for an affected child’s needs.

Cascade Testing

Siblings of carriers have a 50% chance of also being carriers. A positive result is genetic information your entire family can use.

Guideline alignment: The American College of Obstetricians and Gynecologists (ACOG) and the American College of Medical Genetics (ACMG) both recommend that expanded carrier screening be offered to all patients planning pregnancy or in early pregnancy, regardless of ancestry or family history. Horizon meets and exceeds those guidelines.

The Process

How It Works.

From consult to action plan, every step is physician-led.

1
Physician Consult
We review reproductive plans, ancestry, family history, and (if applicable) pregnancy timing. Both partners are encouraged to consult together when feasible.
2
Blood Draw
Single blood draw at our Surfside clinic, performed by a licensed provider. Sample shipped to Natera same-day.
3
Lab Analysis (2-3 weeks)
Natera analyzes 200+ genes using next-generation sequencing. Reports indicate carrier status for each condition tested.
4
Results & Partner Testing
If you are identified as a carrier, we test your reproductive partner for the same condition(s) immediately to clarify pregnancy risk and discuss reproductive options.
Candidates

Who Should Consider.

Carrier screening is recommended for the following groups:

Planning a Pregnancy
Ideally completed before conception so reproductive decisions can be made with complete information.
Currently Pregnant
Recommended in the first trimester if not previously completed; results inform diagnostic options.
Egg or Sperm Donors
Carrier screening is standard for donors; results are typically required by fertility clinics.
Partner of a Known Carrier
If your reproductive partner has tested positive, your screening clarifies pregnancy risk.
Ashkenazi Jewish Ancestry
Elevated carrier frequency for Tay-Sachs, Canavan, Gaucher, Bloom, and other conditions.
Mediterranean Ancestry
Elevated risk of beta-thalassemia carrier status.
African Ancestry
Elevated sickle-cell carrier frequency.
Family History of Genetic Disease
Personal or family history of any inherited condition strengthens the case for screening.
Differentiation

Why TrufaMED for Horizon Carrier Screening.

Why patients choose TrufaMED for Horizon carrier screening:

200+ recessive conditions screened from a single blood draw.

Physician-Ordered, Not Direct-to-Consumer
Carrier screening must be interpreted in clinical context. We do that with you, in person or via telehealth, not via an automated portal.
Both Partners Tested When Possible
Single-partner carrier results are only half the picture. We coordinate partner testing efficiently to provide actionable risk numbers.
Joint Commission-Accredited Facility
The same accreditation hospitals carry. Quality and patient-safety standards are independently audited.
Coordinated Maternal-Fetal Medicine Referral
When both partners carry the same condition, we coordinate referral to maternal-fetal medicine for prenatal diagnosis discussion.
Insurance Navigation
Carrier screening is widely covered during preconception and pregnancy. We verify benefits before sample collection.
IVF/PGT-M Coordination
If both partners carry the same condition and you are pursuing IVF, we coordinate with your fertility clinic on PGT-M (preimplantation genetic testing) workflow.
Pricing & Process

Pricing & Coverage.

Insurance: Most major insurance plans cover Horizon carrier screening when ordered preconception or during pregnancy. Coverage is typically routine and our team verifies benefits in advance.

Self-pay: Self-pay options are available. Call (305) 537-6396 for current pricing.

What is included: Physician consult, test order, blood draw, lab analysis, results review visit, and partner testing coordination if carrier status is identified.

Your Physicians

Physician-Led.

Every order, interpretation, and follow-up is delivered by a board-certified MD.

Dr. Uri Gedalia, MD
General Surgeon · Chief Medical Officer
Dr. Gedalia is a board-certified general surgeon and the Chief Medical Officer of TrufaMED. He oversees clinical protocols including hereditary cancer screening interpretation and the integration of genetic risk into surgical and surveillance decision-making for our patients.
Dr. Shane D. Naidoo, MD
Medical Director · Emergency Medicine
Dr. Naidoo is a board-certified emergency-medicine physician and TrufaMED’s Medical Director. He leads day-to-day physician operations, results-review visits, and coordinates downstream specialist referrals when genetic screening identifies elevated risk requiring further workup.
Visit Us

Visit Us in Surfside, FL.

TrufaMED Urgent Care & Concierge Medicine
9445 Harding Ave
Surfside, FL 33154
Hours: 9 AM – 9 PM, 7 days a week
FAQ

Frequently Asked Questions.

When should we get carrier screening — before or during pregnancy?

Ideally before. Preconception testing gives you the maximum range of reproductive options if both partners are identified as carriers, including IVF with PGT-M, donor gametes, or prenatal diagnosis. If you are already pregnant, screening is best completed in the first trimester.

Does insurance cover Horizon carrier screening?

Most major insurance plans cover carrier screening when ordered preconception or during pregnancy. Our team verifies benefits before any blood is drawn. Self-pay is an option for uncovered patients.

What happens if both partners are carriers of the same condition?

If both partners carry the same recessive mutation, each pregnancy has a 25% chance of producing an affected child. Reproductive options include IVF with PGT-M (testing embryos before transfer), donor gametes, prenatal diagnosis (CVS or amniocentesis), or natural conception with informed acceptance of risk. We discuss every option in detail.

How is this different from a basic 3-gene panel offered elsewhere?

Older minimum panels test only Cystic Fibrosis, SMA, and hemoglobinopathies. Horizon screens for 200+ conditions, identifying carriers for many recessive disorders that would otherwise be missed until an affected child is born.

Can egg or sperm donors use this test?

Yes. Comprehensive carrier screening is standard practice for gamete donors and is typically required by fertility clinics.

Does my ancestry change which panel I should get?

Modern guidance favors a pan-ethnic expanded carrier screening panel for all patients regardless of ancestry, because partner ancestry may differ and self-reported ancestry can be incomplete. Horizon is pan-ethnic by design.

When in pregnancy is it too late to be tested?

It is never too late to gain information, but earlier is better. After the second trimester, prenatal diagnostic options narrow. We can still screen later in pregnancy to inform delivery planning and newborn care.

What is PGT-M and when is it indicated?

PGT-M is preimplantation genetic testing for monogenic disorders — embryos created via IVF are biopsied and tested before transfer, so only unaffected embryos are implanted. It is the most reliable way to avoid passing a known recessive condition to a child when both partners are carriers.

Is the test a blood draw or saliva?

Blood draw, performed by a licensed provider during your in-clinic visit at TrufaMED Surfside.

What if my partner cannot come in?

Sequential testing is acceptable. We test the lower-cost partner first and only test the second partner for conditions where the first was identified as a carrier. This is also possible via mail-in for partners outside South Florida.

How is my genetic data protected?

Natera is HIPAA-compliant and does not share identifiable data with third parties without consent. Federal law (GINA) prevents health insurance and employment discrimination based on genetic information. GINA does not extend to life, disability, or long-term care insurance, which we discuss with you before testing.

Will carrier status affect my own health?

For autosomal recessive conditions, carrier status almost never affects your personal health — only reproductive risk. For some X-linked conditions (Fragile X premutation, Duchenne carrier status), there can be personal health implications, which we discuss when relevant.

Ready to get started?

Speak with a TrufaMED physician about whether horizon carrier screening is appropriate for you.

Genetic screening results require physician interpretation. TrufaMED physicians review every result with you and coordinate any recommended follow-up care, including genetic counselor referral. Screening is not diagnostic — a positive result indicates elevated risk or carrier status, not a current disease state, and confirmatory testing may be indicated. Horizon is offered by Natera under CLIA certification. Natera is the laboratory partner; testing is ordered and interpreted by your TrufaMED physician.